Understanding and designing magnetoelectric heterostructures guided by computation: progresses, remaining questions, and perspectives

Understanding and designing magnetoelectric heterostructures guided by computation: progresses, remaining questions, and perspectives

Magnetoelectric composites and heterostructures integrate magnetic and dielectric materials to produce new functionalities, e.g., magnetoelectric responses that are absent in each of the constituent materials but emerge through the coupling between magnetic order in the magnetic material and electric order in the dielectric material. The magnetoelectric coupling in these composites and heterost...

Large magnetoelectric effect in ferroelectric/piezomagnetic heterostructures

Magnetoelectric quasi-(0-3) nanocomposite heterostructures.

Magnetoelectric composite thin films hold substantial promise for applications in novel multifunctional devices. However, there are presently shortcomings for both the extensively studied bilayer epitaxial (2-2) and vertically architectured nanocomposite (1-3) film systems, restricting their applications. Here we design a novel growth strategy to fabricate an architectured nanocomposite heteros...

Computational analysis of phosphoproteomics: progresses and perspectives.

Phosphorylation is one of the most essential post-translational modifications (PTMs) of proteins, regulates a variety of cellular signaling pathways, and at least partially determines the biological diversity. Recent progresses in phosphoproteomics have identified more than 100,000 phosphorylation sites, while this number will easily exceed one million in the next decade. In this regard, how to...

Optimizing haemodiafiltration: tools, strategy and remaining questions.

Fig. 1. Suggested flow diagram for reporting of long-term major adverse events after coronary angiography with iodinated contrast in the CARE trial. revascularization. Perhaps a future report from the CARE trial can inform the reader about these 38 subjects, particularly those who suffered CI-AKI with respect to their courses of treatment and care in the year of follow-up after the trial. By fi...